Regarding adverse outcomes, our study indicates a trend toward reduced MACE during a 12-month follow-up period in patients treated with TA, although this difference did not reach statistical significance.
← all excerpts
Thrombus aspiration in primary percutaneous coronary intervention in acute ST-elevation myocardial infarction patients with high thrombus burden: one-year outcomes in a tertiary healthcare center in Ho Chi Minh City.
1
—
—